data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRDgwMDI3IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHoiLz48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCAzMTIuODgyaDUxMnYxMTMuNzc1SDB6Ii8+PC9zdmc+

data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+

data:image/svg+xml;base64,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

data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+

data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+

+ New Watchlist

Benzinga Research

-

-

-

-

-

-

-

Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise

data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRDgwMDI3IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHoiLz48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCAzMTIuODgyaDUxMnYxMTMuNzc1SDB6Ii8+PC9zdmc+

data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+

data:image/svg+xml;base64,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

data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+

data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+

Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Yield
How to Buy Corporate Bonds
How to Buy Treasury Bonds
How to Invest in Real Estate Online
Money
Compare Online Brokers
Stock Brokers
Forex Brokers
Futures Brokers
Crypto Brokers
Options Brokers
ETF Brokers
Mutual Fund Brokers
Index Fund Brokers
Bond Brokers
Short Selling Brokers
Stock Apps
All Broker Reviews
Insurance
Auto
Home
Medicare
Life
Vision
Dental
Business
Pet
Health
Motorcycle
Renters
Workers Comp
Top Stocks
Penny Stocks
Stocks Under $5
Stocks Under $10
Stocks Under $20
Stocks Under $50
Stocks Under $100
Alternative Investing
Invest in Art
Invest in Watches
Invest in Land
Invest in Real Estate
Invest in Wine
Invest in Gold
Mortgages
Refinance
Purchase
Find a Mortgage Broker
Alts
Alternative Investment Platforms
REITs Versus Crowdfunding
How to Invest in Artwork
How to Invest in Jewelry
Best Real Estate Crowdfunding Platforms
Best Alternative Investments
Best Alternative Investment Platforms
Crypto
Get Started
Is Bitcoin a Good Investment?
Is Ethereum a Good Investment?
What is Blockchain
Best Altcoins
How to Buy Cryptocurrency?
DeFi
Crypto and DeFi 101
What is DeFi?
Decentralized Exchanges
Best DeFi Yield Farms
Digital Securities
NFTs
NFT Release Calendar
What is a Non-Fungible Token (NFT)?
How to Buy Non-Fungible Tokens (NFTs)
CryptoPunks Watchlist
Are NFTs a Scam or a Digital Bubble?
Best In Crypto
Best Crypto Apps
Best Crypto Portfolio Trackers
Best Crypto Day Trading Strategies
Best Crypto IRA
Best Cryptocurrency Scanners
Best Business Crypto Accounts
Best Crypto Screeners
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Stock Split Calendar

Trade Ideas

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

-

-

-

-

-

-

-

Baxter International Inc

(NYSE:BAX)

GET A REPORT ON BAX SENT RIGHT TO YOUR INBOX

EMAIL*

Perks Buy Compare Brokers

The dividend Ex-Date was 1 day ago

$36.095

0.015[0.04%]

Last update: 10:32AM (Delayed 15-Minutes)
Get Real Time Here

$36.08

-0.0150[-0.04%]

After-Hours

Perks Buy Compare Brokers

Open36.100	Close-
Vol / Avg.522.581K / 5.072M	Mkt Cap18.312B
Day Range35.955 - 36.180	52 Wk Range31.010 - 56.910

0

Latest News for Baxter Intl Stock (NYSE:BAX)

Baxter Intl Stock (NYSE: BAX)

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Monday, November 06, 2023

Baxter Highlights New Data At Kidney Week Indicating Sharesource Is Associated With A 77% Lower Risk Of Home Dialysis Technique Failure
Benzinga Newsdesk - Nov 6, 2023, 8:32AM

Thursday, November 02, 2023

Why Is Dialysis Device And Kidney Care Provider Baxter Stock Trading Higher Today?
Vandana Singh - Nov 2, 2023, 2:50PM
Baxter International shares are trading higher after the company reported better-than-expected Q3 financial results and issued Q4 and FY23 guidance.
Benzinga Newsdesk - Nov 2, 2023, 11:59AM
Baxter Expects Q4 FY23 Sales Growth From Continuing Operations Of 1% To 2% On A Reported Basis And Approximately 1% On A Constant Currency Basis
Benzinga Newsdesk - Nov 2, 2023, 7:24AM
Baxter Expects Q4 FY23 Adjusted EPS From Continuing Operations Of $0.85-$0.88 Versus Consensus Of $0.84
Benzinga Newsdesk - Nov 2, 2023, 7:23AM
Baxter Expects Sales Growth From Continuing Operations Of 1%-2% On A Reported Basis And Approximately 2% On A Constant Currency Basis
Benzinga Newsdesk - Nov 2, 2023, 7:22AM
Baxter Expects FY23 Adjusted EPS From Continuing Operations Of $2.57-$2.60 Versus Consensus Of $2.59
Benzinga Newsdesk - Nov 2, 2023, 7:21AM
Baxter Intl Q3 Adjusted EPS $0.82 Beats $0.68 Estimate, Sales $3.71B Beat $3.69B Estimate
Benzinga Newsdesk - Nov 2, 2023, 7:19AM
Earnings Scheduled For November 2, 2023
Benzinga Insights - Nov 2, 2023, 4:56AM

Wednesday, November 01, 2023

Earnings Outlook For Baxter Intl
Benzinga Insights - Nov 1, 2023, 10:02AM

Tuesday, October 31, 2023

JP Morgan Maintains Neutral on Baxter Intl, Lowers Price Target to $36
Benzinga Newsdesk - Oct 31, 2023, 4:08PM

Wednesday, October 11, 2023

Why Astra Space Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Lisa Levin - Oct 11, 2023, 1:13PM
Shares of dialysis providers and kidney care stocks are trading lower after Novo Nordisk stopped its semaglutide kidney outcomes trial early based on early signs of efficacy.
Bill Haddad - Oct 11, 2023, 11:03AM
What's Going On With Kidney Dialysis Provider Stocks Today?
Vandana Singh - Oct 11, 2023, 9:52AM
Silk Road Medical, E2open And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Lisa Levin - Oct 11, 2023, 6:00AM

Tuesday, October 10, 2023

12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights - Oct 10, 2023, 5:32PM

Tuesday, October 03, 2023

Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights - Oct 3, 2023, 2:37PM
Baxter Has Appointed Joel Grade As Executive Vice President & CFO, Effective October 18. Brian Stevens, Who Has Served As The Interim CFO Since May 31, Will Move To His Prior Role As SVP, Chief Accounting Officer, Controller
Benzinga Newsdesk - Oct 3, 2023, 9:07AM

Tuesday, September 26, 2023

Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights - Sep 26, 2023, 12:04PM

Friday, September 15, 2023

10 Health Care Stocks Whale Activity In Today's Session
Benzinga Insights - Sep 15, 2023, 1:35PM

Monday, August 21, 2023

7 Analysts Have This to Say About Baxter Intl
Benzinga Insights - Aug 21, 2023, 9:00AM
Citigroup Maintains Neutral on Baxter Intl, Lowers Price Target to $45
Benzinga Newsdesk - Aug 21, 2023, 7:21AM

Tuesday, August 01, 2023

Barclays Maintains Overweight on Baxter Intl, Lowers Price Target to $54
Benzinga Newsdesk - Aug 1, 2023, 8:53AM

Monday, July 31, 2023

Software Update Leads To False Alarms In Baxter's Spectrum Infusion Pumps, Urgent Correction Underway
Vandana Singh - Jul 31, 2023, 12:57PM
Baxter International shares are trading lower after the the company issued an Urgent Medical Device Correction for its Spectrum V8 and Spectrum IQ pumps with specific software versions.
Benzinga Newsdesk - Jul 31, 2023, 10:40AM
FDA Says Correction By Baxter Due To Increase In Reported False Upstream Occlusion Alarms Following Software Upgrades In Spectrum V8 & IQ Infusion Pumps
Happy Mohamed - Jul 31, 2023, 9:48AM
FDA Says Baxter Issues Urgent Medical Device Correction For Spectrum V8 And Spectrum IQ Infusion Pumps With Specific Software Versions; Baxter Received 3 Reports Of Serious Injury Potentially Associated With Medical Device Correction
Happy Mohamed - Jul 31, 2023, 9:47AM
Apple To Rally Over 12%? Here Are 10 Other Analyst Forecasts For Monday
Lisa Levin - Jul 31, 2023, 8:06AM
Barclays Maintains Overweight on Baxter Intl, Lowers Price Target to $54
Benzinga Newsdesk - Jul 31, 2023, 6:08AM
Keybanc Maintains Overweight on Baxter Intl, Lowers Price Target to $51
Benzinga Newsdesk - Jul 31, 2023, 4:17AM

Friday, July 28, 2023

What 4 Analyst Ratings Have To Say About Baxter Intl
Benzinga Insights - Jul 28, 2023, 3:00PM
Wells Fargo Maintains Equal-Weight on Baxter Intl, Lowers Price Target to $44
Benzinga Newsdesk - Jul 28, 2023, 11:39AM

Thursday, July 27, 2023

Baxter International shares are trading lower after the company reported worse-than-expected revenue results and issued Q3 and FY23 adjusted EPS guidance.
Benzinga Newsdesk - Jul 27, 2023, 3:28PM
Baxter Posts Mixed Q2 Earnings, Stock Falls On Lagging FY23 Outlook
Vandana Singh - Jul 27, 2023, 11:07AM
Baxter Expects Q3 FY23 Adjusted EPS (Including Discontinued Operations) of $0.78-$0.80 And $0.65-$0.67 From Continuing Operations Compared To Consensus Of $0.80
Benzinga Newsdesk - Jul 27, 2023, 7:35AM
Baxter Intl Q2 Adjusted EPS $0.66 Beats $0.60 Estimate, Sales $3.71B Miss $3.79B Estimate
Benzinga Newsdesk - Jul 27, 2023, 7:31AM
Earnings Scheduled For July 27, 2023
Benzinga Insights - Jul 27, 2023, 4:34AM

Tuesday, July 25, 2023

Baxter Announced That Vantive Will Be The Name Of The Company's Proposed Spinoff Of Its Renal Care And Acute Therapies Businesses; Vantive Is Expected To Launch As An Independent, Publicly Traded Company By July 2024 Or Earlier
Benzinga Newsdesk - Jul 25, 2023, 8:17AM

Monday, July 24, 2023

Baxter International Launched PERCLOT Absorbable Hemostatic Powder In The U.S., Ready To Use And Designed For Patients With Intact Coagulation To Address Mild Bleeding
Benzinga Newsdesk - Jul 24, 2023, 8:09AM

Wednesday, July 12, 2023

Baxter's Upcoming Q2 Earnings: Analyst Says Consistent Performance, Catalysts Can Accelerate Growth & Margins
Vandana Singh - Jul 12, 2023, 1:53PM
Stifel Maintains Buy on Baxter Intl, Raises Price Target to $56
Benzinga Newsdesk - Jul 12, 2023, 10:49AM

Thursday, June 29, 2023

10 Health Care Stocks Whale Activity In Today's Session
Benzinga Insights - Jun 29, 2023, 1:39PM

Tuesday, May 30, 2023

Analyst Expectations for Baxter Intl's Future
Benzinga Insights - May 30, 2023, 1:01PM
Morgan Stanley Assumes Baxter Intl at Equal-Weight, Announces Price Target of $45
Benzinga Newsdesk - May 30, 2023, 7:09AM

Tuesday, May 23, 2023

Artivion Announces FDA PMA Approval of PerClot and Transfer of PMA to Baxter
Benzinga Newsdesk - May 23, 2023, 8:05AM

Tuesday, May 09, 2023

Baxter shares are trading lower after the company announced a CFO transition.
Benzinga Newsdesk - May 9, 2023, 12:34PM
Baxter Does Not Expect Any Changes To Its Financial Guidance Previously Issued On April 27, 2023
Benzinga Newsdesk - May 9, 2023, 8:17AM
Baxter Reports Departure Of CFO Jay Saccaro; Brian Stevens Named Interim CFO
Benzinga Newsdesk - May 9, 2023, 8:16AM

Monday, May 08, 2023

Baxter International Shares Resume Trade Following News Pending Halt
Happy Mohamed - May 8, 2023, 10:17AM
Baxter Signs Definitive Agreement To Divest Its BioPharma Solutions Business To Advent International And Warburg Pincus For $4.25B
Happy Mohamed - May 8, 2023, 9:59AM

1
2
3
4
5
6
7
Next
17

Popular Channels

PreMarket Prep
Press Releases
Analyst Ratings
News
Options
ETFs

Tools & Features

Real Time Feed
Public RSS Feeds
Submit News Tips
Blog
Embeddable Finance Widgets & Tools
Benzinga Catalyst

Partners & Contributors

Affiliate Program
Contributor Portal
Licensing & Syndication
Sponsored Content
Advertise With Us
Lead Generation & SEO

About Benzinga

About Us
Careers
In The News
Events
Contact Us

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2023 Benzinga | All Rights Reserved